Ixekizumab

Item number	Size	Delivery time	Price
TGM-T38105-1mg	1 mg	7 - 10 business days*	139.00€
TGM-T38105-5mg	5 mg	7 - 10 business days*	461.00€
TGM-T38105-10mg	10 mg	7 - 10 business days*	677.00€
TGM-T38105-25mg	25 mg	7 - 10 business days*	1,070.00€
TGM-T38105-50mg	50 mg	7 - 10 business days*	1,430.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Ixekizumab (LY2439821) is a humanized IgG4 monoclonal antibody that selectively... more

Close menu

Product information "Ixekizumab"

Description: Ixekizumab (LY2439821) is a humanized IgG4 monoclonal antibody that selectively binds and neutralizes interleukin IL-17A with a Kd value of <3 pM. It blocks the binding of IL-17A to IL-17RA but not to other IL-17 family members. Ixekizumab is used for the treatment of moderate to severe plaque psoriasis, psoriasis, arthritis, and psoriasis. Target: Interleukin, IL Receptor. Smiles: N/A. References: Liu L, et al. Generation and characterization of ixekizumab, a humanized monoclonal antibody that neutralizes interleukin-17A. J Inflamm Res. 2016,9:39-50.

Keywords:	LY2439821
Supplier:	TargetMol
Supplier-Nr:	T38105

Properties

Application:	Targets interleukin 17A (IL17A, CTLA8)
Conjugate:	No

Database Information

CAS :	1143503-69-8\| Matching products
KEGG ID :	K05489 \| Matching products

Handling & Safety

Storage:	+4°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Ixekizumab"

Write a review